Endpoints News· @endpts · X·· 5 小时前AI 评分42
AI 导读
Paragon最新的分拆公司Velaris通过与Alaunos反向合并上市，将其心肺药物注入该生物技术公司。https://endpoints.news/paragon-spins-out-ninth-biotech-sending-cardiopulmonary-drugs-to-alaunos/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
正文
Paragon’s latest spinout, Velaris, went public through a reverse merger with Alaunos, sending its cardiopulmonary drugs to the biotech. https://endpoints.news/paragon-spins-out-ninth-biotech-sending-cardiopulmonary-drugs-to-alaunos/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源：Endpoints News · x.com